An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes
August 18th, 2018
A tandem RNA isolation procedure (TRIP) for recovery of endogenously formed mRNA-protein complexes is described. Specifically, RNA-protein complexes are crosslinked in vivo, polyadenylated RNAs are isolated from extracts with oligo(dT) beads, and particular mRNAs are captured with modified RNA antisense oligonucleotides. Proteins bound to mRNAs are detected by immunoblot analysis.
Overview
This article describes a tandem RNA isolation procedure (TRIP) for recovering endogenously formed mRNA-protein complexes. The method allows for the detection of proteins bound to mRNAs through immunoblot analysis.
Key Study Components
Area of Science
- Gene expression regulation
- RNA-protein interactions
- Post-transcriptional regulation
Background
- Understanding how RNA-binding proteins assemble on RNAs is crucial for gene regulation.
- The technique does not require cloning or genetic manipulation.
- It can be adapted for various model organisms.
- Designing oligonucleotides involves analyzing mRNA secondary structures.
Purpose of Study
- To develop a method for isolating mRNA-protein complexes.
- To facilitate the study of post-transcriptional gene regulation.
- To provide a versatile tool for researchers in molecular biology.
Methods Used
- Crosslinking RNA-protein complexes in vivo.
- Isolating polyadenylated RNAs using oligo(dT) beads.
- Capturing specific mRNAs with modified antisense oligonucleotides.
- Detecting bound proteins through immunoblot analysis.
Main Results
- The TRIP method successfully isolates mRNA-protein complexes.
- Specific mRNAs can be captured and analyzed.
- Immunoblot analysis reveals protein interactions with mRNAs.
Conclusions
- The TRIP method is a valuable tool for studying gene regulation.
- It allows for the exploration of RNA-protein interactions in various organisms.
- This technique enhances our understanding of post-transcriptional mechanisms.
Frequently Asked Questions
Executive Industry Relevance
Precise isolation of endogenous mRNA-protein complexes is critical for de-risking target validation and understanding post-transcriptional gene regulation in early discovery. The TRIP procedure enables direct interrogation of RNA-protein interactions across model systems without genetic manipulation, supporting predictive confidence in mechanistic studies. This capability strengthens portfolio decisions by clarifying functional RNA-protein assemblies relevant to disease and development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables biochemical dissection of mRNA-protein complexes in vivo for functional target validation.
- Supports mechanistic de-risking by revealing endogenous RNA-protein interaction networks.
- Facilitates hypothesis-driven interrogation of post-transcriptional regulatory pathways.
- Provides a platform for identifying candidate RBPs as potential therapeutic targets.
Screening & Assay Development
- Delivers validated mRNP complexes for downstream immunoblot or mass spectrometry analysis.
- Standardizes capture of specific mRNAs using sequence-defined antisense oligonucleotides.
- Enables reproducible, quantitative assessment of protein binding to target RNAs.
- Prepares samples for scalable screening of RNA-protein interactions under varied conditions.
Translational & Preclinical Research
- Aligns with disease-relevant systems by capturing mRNPs from human, yeast, or nematode cells.
- Supports continuity from discovery to preclinical validation of RNA-protein targets.
- Enables investigation of dynamic mRNP rearrangements in response to environmental or developmental cues.
- Facilitates identification of translational biomarkers linked to RNA-protein complexes.
Pipeline & Workflow Integration
The TRIP method integrates at the interface of early discovery and lead identification, providing a reusable workflow for isolating and characterizing mRNA-protein complexes across diverse biological models.
- Discovery Biology: Advances hypothesis testing by enabling direct capture and analysis of endogenous mRNPs.
- Screening: Supplies standardized, quantitative outputs for comparing RNA-protein binding across conditions.
- Analytics: Supports immunoblot and mass spectrometry readouts for comprehensive protein identification.
- Translational Research: Bridges discovery and preclinical studies by enabling analysis in disease-relevant cell types.
- Enterprise Reuse: Adaptable to any polyadenylated RNA, supporting broad application across R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in RNA-protein target validation and mechanistic studies.
- Operational Value: Delivers standardized, reproducible isolation of mRNPs without genetic modification.
- Strategic Value: Improves go/no-go decisions by clarifying functional RNA-protein assemblies.
- Portfolio Impact: Enables risk-adjusted prioritization of RNA-protein targets for advancement.
Implementation Considerations
- Requires expertise in oligonucleotide design and RNA secondary structure analysis.
- Needs access to crosslinking, magnetic bead isolation, and analytical platforms (immunoblot, mass spectrometry).
- Demands cross-team standardization of oligonucleotide selection and hybridization conditions.
- Adaptable across model organisms and cell types with polyadenylated RNAs.
- Dependent on careful control of hybridization specificity and avoidance of cross-hybridization.
Biopharma FAQs
Chapters in this video
0:04
Title
0:32
Antisense Oligonucleotide (ASO) Design
2:22
Protein Extract Preparation
4:08
Step 1: Poly(A) RNA Isolation
5:45
Step 2: Specific mRNA Capture with 3 -Biotinylated 2 -Methoxy Modified Antisense RNA Oligonucleotides
7:41
Results: Capture of Specific mRNA-protein Complexes from Extracts Derived from UV Crosslinked Cells with TRIP
9:00
Conclusion
